LC-MS based stability-indicating method for studying the degradation of lonidamine under physical and chemical stress conditions

Background and purpose: Lonidamine is a hexokinase II inhibitor, works as an anticancer molecule, and is extensively explored in clinical trials. Limited information prevails about the stability-indicating methods which could determine the forced degradation of lonidamine under stressed conditions....

Full description

Saved in:
Bibliographic Details
Main Authors: Ankit Kanaiyalal Rochani (Author), Margaret Wheatley (Author), Brian Edward Oeffinger (Author), John Robert Eisenbrey (Author), Gagan Kaushal (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_70b15676550f42b4aa4d7190b18c4722
042 |a dc 
100 1 0 |a Ankit Kanaiyalal Rochani  |e author 
700 1 0 |a Margaret Wheatley  |e author 
700 1 0 |a Brian Edward Oeffinger  |e author 
700 1 0 |a John Robert Eisenbrey  |e author 
700 1 0 |a Gagan Kaushal  |e author 
245 0 0 |a LC-MS based stability-indicating method for studying the degradation of lonidamine under physical and chemical stress conditions 
260 |b Wolters Kluwer Medknow Publications,   |c 2020-01-01T00:00:00Z. 
500 |a 1735-5362 
500 |a 1735-9414 
500 |a 10.4103/1735-5362.293509 
520 |a Background and purpose: Lonidamine is a hexokinase II inhibitor, works as an anticancer molecule, and is extensively explored in clinical trials. Limited information prevails about the stability-indicating methods which could determine the forced degradation of lonidamine under stressed conditions. Hence, we report the use of a rapid, sensitive, reproducible, and highly accurate liquid chromatography and mass spectrometry method to analyze lonidamine degradation. Experimental approach: The Xbridge BEH shield reverse phase C18 column (2.5 μm, 4.6 × 75 mm) using isocratic 50:50 water: acetonitrile with 0.1% formic acid can detect lonidamine with help of mass spectrometer in tandem with an ultraviolet (UV) detector at 260 nm wavelength. Findings/ Results: A linear curve with r2 > 0.99 was obtained for tandem liquid chromatography-mass spectrometry (LC-MS)-UV based detections. This study demonstrated (in the present set up of isocratic elution) that LC-MS based detection has a relatively high sensitivity (S/N (10 ng/mL): 220 and S/N (20 ng/mL): 945) and accuracy at lower detection and quantitation levels, respectively. In addition to developing the LC-MS method, we also report that the current method is stability-indicating and shows that lonidamine gets degraded over time under all three stress conditions; acidic, basic, and oxidative. Conclusion and implications: LC-MS based quantitation of lonidamine proved to be a better method compared to high-performance liquid chromatography (HPLC)-UV detections for mapping lonidamine degradation. This is the first report on the stability-indicating method for studying the forced degradation of lonidamine using LC-MS method. 
546 |a EN 
690 |a forced degradation; lc-ms; lonidamine; stability indicating 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Research in Pharmaceutical Sciences, Vol 15, Iss 4, Pp 312-322 (2020) 
787 0 |n http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2020;volume=15;issue=4;spage=312;epage=322;aulast=Rochani 
787 0 |n https://doaj.org/toc/1735-5362 
787 0 |n https://doaj.org/toc/1735-9414 
856 4 1 |u https://doaj.org/article/70b15676550f42b4aa4d7190b18c4722  |z Connect to this object online.